Listed

BriaCell Therapeutics Corp.

BCTXNasdaqCIK 1610820HealthcareFiscal year ends Jul 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$7.6m, Q3 FY2026
Net income−$7.2m, Q3 FY2026
Line itemUnitQ4 FY20232023-07-31Q1 FY20242023-10-31Q2 FY20242024-01-31Q3 FY20242024-04-30Q4 FY20242024-07-31Q1 FY20252024-10-31Q2 FY20252025-01-31Q3 FY20252025-04-30Q4 FY20252025-07-31Q1 FY20262025-10-31Q2 FY20262026-01-31Q3 FY20262026-04-30
Research and development$m5.2Research and development, Q4 FY2023, three months to 2023-07-31$5.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2024-10-29, accession 0001493152-24-042743. Derived: 12-month figure less the 9-month figure.Report this figure6.9Research and development, Q1 FY2024, three months to 2023-10-31$6.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-12-16, accession 0001493152-24-050214.Report this figure8.3Research and development, Q2 FY2024, three months to 2024-01-31$8.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-03-12, accession 0001493152-25-010052.Report this figure7.7Research and development, Q3 FY2024, three months to 2024-04-30$7.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-06-16, accession 0001641172-25-015265.Report this figure4.4Research and development, Q4 FY2024, three months to 2024-07-31$4.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-10-16, accession 0001493152-25-018212. Derived: 12-month figure less the 9-month figure.Report this figure3.7Research and development, Q1 FY2025, three months to 2024-10-31$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure5.7Research and development, Q2 FY2025, three months to 2025-01-31$5.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure4.8Research and development, Q3 FY2025, three months to 2025-04-30$4.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure7.1Research and development, Q4 FY2025, three months to 2025-07-31$7.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-10-16, accession 0001493152-25-018212. Derived: 12-month figure less the 9-month figure.Report this figure6.7Research and development, Q1 FY2026, three months to 2025-10-31$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure6.1Research and development, Q2 FY2026, three months to 2026-01-31$6.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure6.0Research and development, Q3 FY2026, three months to 2026-04-30$6.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure
Operating income$m(7.7)Operating income, Q4 FY2023, three months to 2023-07-31−$7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-10-29, accession 0001493152-24-042743. Derived: 12-month figure less the 9-month figure.Report this figure(8.5)Operating income, Q1 FY2024, three months to 2023-10-31−$8.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-12-16, accession 0001493152-24-050214.Report this figure(9.8)Operating income, Q2 FY2024, three months to 2024-01-31−$9.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-03-12, accession 0001493152-25-010052.Report this figure(9.2)Operating income, Q3 FY2024, three months to 2024-04-30−$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-06-16, accession 0001641172-25-015265.Report this figure(5.8)Operating income, Q4 FY2024, three months to 2024-07-31−$5.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-10-16, accession 0001493152-25-018212. Derived: 12-month figure less the 9-month figure.Report this figure(5.2)Operating income, Q1 FY2025, three months to 2024-10-31−$5.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure(7.2)Operating income, Q2 FY2025, three months to 2025-01-31−$7.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure(6.3)Operating income, Q3 FY2025, three months to 2025-04-30−$6.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure(8.6)Operating income, Q4 FY2025, three months to 2025-07-31−$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-10-16, accession 0001493152-25-018212. Derived: 12-month figure less the 9-month figure.Report this figure(8.3)Operating income, Q1 FY2026, three months to 2025-10-31−$8.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure(7.5)Operating income, Q2 FY2026, three months to 2026-01-31−$7.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure(7.6)Operating income, Q3 FY2026, three months to 2026-04-30−$7.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reportednot reported0.0Interest expense, Q3 FY2025, three months to 2025-04-30$37.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure0.0Interest expense, Q4 FY2025, three months to 2025-07-31$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2025-10-16, accession 0001493152-25-018212. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reported0.0Interest expense, Q3 FY2026, three months to 2026-04-30$29.6k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure
Net income$m(2.4)Net income, Q4 FY2023, three months to 2023-07-31−$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-10-29, accession 0001493152-24-042743. Derived: 12-month figure less the 9-month figure.Report this figure6.0Net income, Q1 FY2024, three months to 2023-10-31$6.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-12-16, accession 0001493152-24-050214.Report this figure(11.3)Net income, Q2 FY2024, three months to 2024-01-31−$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-03-12, accession 0001493152-25-010052.Report this figure1.7Net income, Q3 FY2024, three months to 2024-04-30$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-06-16, accession 0001641172-25-015265.Report this figure(1.2)Net income, Q4 FY2024, three months to 2024-07-31−$1.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-10-16, accession 0001493152-25-018212. Derived: 12-month figure less the 9-month figure.Report this figure(5.8)Net income, Q1 FY2025, three months to 2024-10-31−$5.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure(6.3)Net income, Q2 FY2025, three months to 2025-01-31−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure(6.1)Net income, Q3 FY2025, three months to 2025-04-30−$6.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure(8.1)Net income, Q4 FY2025, three months to 2025-07-31−$8.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-10-16, accession 0001493152-25-018212. Derived: 12-month figure less the 9-month figure.Report this figure(8.2)Net income, Q1 FY2026, three months to 2025-10-31−$8.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure(7.2)Net income, Q2 FY2026, three months to 2026-01-31−$7.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure(7.2)Net income, Q3 FY2026, three months to 2026-04-30−$7.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure
Diluted EPS$ per sharenot reported(0.50)Diluted EPS, Q1 FY2024, three months to 2023-10-31−$0.50 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-12-16, accession 0001493152-24-050214.Report this figure(10.64)Diluted EPS, Q2 FY2024, three months to 2024-01-31−$10.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-03-12, accession 0001493152-25-010052.Report this figure1.61Diluted EPS, Q3 FY2024, three months to 2024-04-30$1.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-06-16, accession 0001641172-25-015265.Report this figurenot reported(32.67)Diluted EPS, Q1 FY2025, three months to 2024-10-31−$32.67 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure(23.31)Diluted EPS, Q2 FY2025, three months to 2025-01-31−$23.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure(16.42)Diluted EPS, Q3 FY2025, three months to 2025-04-30−$16.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figurenot reported(4.35)Diluted EPS, Q1 FY2026, three months to 2025-10-31−$4.35 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure(2.58)Diluted EPS, Q2 FY2026, three months to 2026-01-31−$2.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure(0.99)Diluted EPS, Q3 FY2026, three months to 2026-04-30−$0.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure
Basic EPS$ per sharenot reported0.38Basic EPS, Q1 FY2024, three months to 2023-10-31$0.38 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-12-16, accession 0001493152-24-050214.Report this figure(10.64)Basic EPS, Q2 FY2024, three months to 2024-01-31−$10.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-03-12, accession 0001493152-25-010052.Report this figure1.61Basic EPS, Q3 FY2024, three months to 2024-04-30$1.61 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-06-16, accession 0001641172-25-015265.Report this figurenot reported(32.67)Basic EPS, Q1 FY2025, three months to 2024-10-31−$32.67 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure(23.31)Basic EPS, Q2 FY2025, three months to 2025-01-31−$23.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure(16.42)Basic EPS, Q3 FY2025, three months to 2025-04-30−$16.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figurenot reported(4.35)Basic EPS, Q1 FY2026, three months to 2025-10-31−$4.35 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure(2.58)Basic EPS, Q2 FY2026, three months to 2026-01-31−$2.58 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure(0.99)Basic EPS, Q3 FY2026, three months to 2026-04-30−$0.99 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure

Balance sheet

Cash and equivalents$6.9m, Q3 FY2026
Shareholders' equity$23.4m, Q3 FY2026
Line itemUnitFY20232023-07-31Q1 FY20242023-10-31Q2 FY20242024-01-31Q3 FY20242024-04-30FY20242024-07-31Q1 FY20252024-10-31Q2 FY20252025-01-31Q3 FY20252025-04-30FY20252025-07-31Q1 FY20262025-10-31Q2 FY20262026-01-31Q3 FY20262026-04-30
Cash and equivalents$m21.3Cash and equivalents, FY2023, at 2023-07-31$21.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2024-10-29, accession 0001493152-24-042743.Report this figure13.6Cash and equivalents, Q1 FY2024, at 2023-10-31$13.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-12-14, accession 0001493152-23-044892.Report this figure6.2Cash and equivalents, Q2 FY2024, at 2024-01-31$6.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-03-18, accession 0001493152-24-010354.Report this figure0.9Cash and equivalents, Q3 FY2024, at 2024-04-30$935.7k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-06-14, accession 0001493152-24-023867.Report this figure0.9Cash and equivalents, FY2024, at 2024-07-31$862.1k. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-10-16, accession 0001493152-25-018212.Report this figure5.8Cash and equivalents, Q1 FY2025, at 2024-10-31$5.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-12-16, accession 0001493152-24-050214.Report this figure5.0Cash and equivalents, Q2 FY2025, at 2025-01-31$5.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-03-12, accession 0001493152-25-010052.Report this figure12.5Cash and equivalents, Q3 FY2025, at 2025-04-30$12.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-06-16, accession 0001641172-25-015265.Report this figure10.5Cash and equivalents, FY2025, at 2025-07-31$10.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure2.7Cash and equivalents, Q1 FY2026, at 2025-10-31$2.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure29.9Cash and equivalents, Q2 FY2026, at 2026-01-31$29.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure6.9Cash and equivalents, Q3 FY2026, at 2026-04-30$6.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure
Current assets$m26.9Current assets, FY2023, at 2023-07-31$26.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2024-10-29, accession 0001493152-24-042743.Report this figure18.4Current assets, Q1 FY2024, at 2023-10-31$18.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-12-14, accession 0001493152-23-044892.Report this figure11.7Current assets, Q2 FY2024, at 2024-01-31$11.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-03-18, accession 0001493152-24-010354.Report this figure5.5Current assets, Q3 FY2024, at 2024-04-30$5.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-06-14, accession 0001493152-24-023867.Report this figure3.7Current assets, FY2024, at 2024-07-31$3.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-10-16, accession 0001493152-25-018212.Report this figure8.2Current assets, Q1 FY2025, at 2024-10-31$8.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-12-16, accession 0001493152-24-050214.Report this figure7.2Current assets, Q2 FY2025, at 2025-01-31$7.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-03-12, accession 0001493152-25-010052.Report this figure14.8Current assets, Q3 FY2025, at 2025-04-30$14.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-06-16, accession 0001641172-25-015265.Report this figure19.9Current assets, FY2025, at 2025-07-31$19.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure11.3Current assets, Q1 FY2026, at 2025-10-31$11.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure32.2Current assets, Q2 FY2026, at 2026-01-31$32.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure25.4Current assets, Q3 FY2026, at 2026-04-30$25.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure
Total assets$m27.2Total assets, FY2023, at 2023-07-31$27.2m. XBRL concept us-gaap:Assets. 10-K filed 2024-10-29, accession 0001493152-24-042743.Report this figure18.6Total assets, Q1 FY2024, at 2023-10-31$18.6m. XBRL concept us-gaap:Assets. 10-Q filed 2023-12-14, accession 0001493152-23-044892.Report this figure12.2Total assets, Q2 FY2024, at 2024-01-31$12.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-03-18, accession 0001493152-24-010354.Report this figure6.2Total assets, Q3 FY2024, at 2024-04-30$6.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-06-14, accession 0001493152-24-023867.Report this figure5.9Total assets, FY2024, at 2024-07-31$5.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-10-16, accession 0001493152-25-018212.Report this figure10.4Total assets, Q1 FY2025, at 2024-10-31$10.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-12-16, accession 0001493152-24-050214.Report this figure9.4Total assets, Q2 FY2025, at 2025-01-31$9.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-03-12, accession 0001493152-25-010052.Report this figure17.0Total assets, Q3 FY2025, at 2025-04-30$17.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-06-16, accession 0001641172-25-015265.Report this figure21.6Total assets, FY2025, at 2025-07-31$21.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure13.1Total assets, Q1 FY2026, at 2025-10-31$13.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure33.6Total assets, Q2 FY2026, at 2026-01-31$33.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure27.1Total assets, Q3 FY2026, at 2026-04-30$27.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure
Current liabilities$m1.8Current liabilities, FY2023, at 2023-07-31$1.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2024-10-29, accession 0001493152-24-042743.Report this figure1.0Current liabilities, Q1 FY2024, at 2023-10-31$1.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-12-14, accession 0001493152-23-044892.Report this figure3.9Current liabilities, Q2 FY2024, at 2024-01-31$3.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-03-18, accession 0001493152-24-010354.Report this figure6.8Current liabilities, Q3 FY2024, at 2024-04-30$6.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-06-14, accession 0001493152-24-023867.Report this figure7.5Current liabilities, FY2024, at 2024-07-31$7.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-10-16, accession 0001493152-25-018212.Report this figure5.0Current liabilities, Q1 FY2025, at 2024-10-31$5.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-12-16, accession 0001493152-24-050214.Report this figure5.2Current liabilities, Q2 FY2025, at 2025-01-31$5.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-03-12, accession 0001493152-25-010052.Report this figure4.3Current liabilities, Q3 FY2025, at 2025-04-30$4.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-06-16, accession 0001641172-25-015265.Report this figure4.0Current liabilities, FY2025, at 2025-07-31$4.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure3.3Current liabilities, Q1 FY2026, at 2025-10-31$3.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure3.2Current liabilities, Q2 FY2026, at 2026-01-31$3.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure3.6Current liabilities, Q3 FY2026, at 2026-04-30$3.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure
Shareholders' equity$m(3.8)Shareholders' equity, FY2023, at 2023-07-31−$3.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2023-10-25, accession 0001493152-23-038298.Report this figure2.5Shareholders' equity, Q1 FY2024, at 2023-10-31$2.5m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-03-12, accession 0001493152-25-010052.Report this figure(8.3)Shareholders' equity, Q2 FY2024, at 2024-01-31−$8.3m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-06-16, accession 0001641172-25-015265.Report this figure(6.2)Shareholders' equity, Q3 FY2024, at 2024-04-30−$6.2m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-06-16, accession 0001641172-25-015265.Report this figure(2.7)Shareholders' equity, FY2024, at 2024-07-31−$2.7m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure3.7Shareholders' equity, Q1 FY2025, at 2024-10-31$3.7m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure3.2Shareholders' equity, Q2 FY2025, at 2025-01-31$3.2m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure11.9Shareholders' equity, Q3 FY2025, at 2025-04-30$11.9m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure17.3Shareholders' equity, FY2025, at 2025-07-31$17.3m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure9.4Shareholders' equity, Q1 FY2026, at 2025-10-31$9.4m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure30.2Shareholders' equity, Q2 FY2026, at 2026-01-31$30.2m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure23.4Shareholders' equity, Q3 FY2026, at 2026-04-30$23.4m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure

Cash flow

Operating cash flow−$7.0m, Q3 FY2026
Line itemUnitQ4 FY20232023-07-31Q1 FY20242023-10-31Q2 FY20242024-01-31Q3 FY20242024-04-30Q4 FY20242024-07-31Q1 FY20252024-10-31Q2 FY20252025-01-31Q3 FY20252025-04-30Q4 FY20252025-07-31Q1 FY20262025-10-31Q2 FY20262026-01-31Q3 FY20262026-04-30
Operating cash flow$m(10.9)Operating cash flow, Q4 FY2023, three months to 2023-07-31−$10.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-10-29, accession 0001493152-24-042743. Derived: 12-month figure less the 9-month figure.Report this figure(7.6)Operating cash flow, Q1 FY2024, three months to 2023-10-31−$7.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-12-16, accession 0001493152-24-050214.Report this figure(7.4)Operating cash flow, Q2 FY2024, three months to 2024-01-31−$7.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-03-12, accession 0001493152-25-010052. Derived: 6-month figure less the 3-month figure.Report this figure(5.1)Operating cash flow, Q3 FY2024, three months to 2024-04-30−$5.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-06-16, accession 0001641172-25-015265. Derived: 9-month figure less the 6-month figure.Report this figure(4.0)Operating cash flow, Q4 FY2024, three months to 2024-07-31−$4.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-10-16, accession 0001493152-25-018212. Derived: 12-month figure less the 9-month figure.Report this figure(7.0)Operating cash flow, Q1 FY2025, three months to 2024-10-31−$7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure(5.9)Operating cash flow, Q2 FY2025, three months to 2025-01-31−$5.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-03-10, accession 0001493152-26-009557. Derived: 6-month figure less the 3-month figure.Report this figure(7.2)Operating cash flow, Q3 FY2025, three months to 2025-04-30−$7.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-06-09, accession 0001493152-26-027928. Derived: 9-month figure less the 6-month figure.Report this figure(8.1)Operating cash flow, Q4 FY2025, three months to 2025-07-31−$8.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-10-16, accession 0001493152-25-018212. Derived: 12-month figure less the 9-month figure.Report this figure(7.7)Operating cash flow, Q1 FY2026, three months to 2025-10-31−$7.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure(8.0)Operating cash flow, Q2 FY2026, three months to 2026-01-31−$8.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-03-10, accession 0001493152-26-009557. Derived: 6-month figure less the 3-month figure.Report this figure(7.0)Operating cash flow, Q3 FY2026, three months to 2026-04-30−$7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-06-09, accession 0001493152-26-027928. Derived: 9-month figure less the 6-month figure.Report this figure

Shares

Diluted shares (weighted)7.25m, Q3 FY2026
Line itemUnitQ1 FY20232022-10-31Q2 FY20232023-01-31Q3 FY20232023-04-30Q1 FY20242023-10-31Q2 FY20242024-01-31Q3 FY20242024-04-30Q1 FY20252024-10-31Q2 FY20252025-01-31Q3 FY20252025-04-30Q1 FY20262025-10-31Q2 FY20262026-01-31Q3 FY20262026-04-30
Diluted shares (weighted)m shares15.5Diluted shares (weighted), Q1 FY2023, three months to 2022-10-3115,518,018 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-12-14, accession 0001493152-23-044892.Report this figure15.5Diluted shares (weighted), Q2 FY2023, three months to 2023-01-3115,518,018 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-03-18, accession 0001493152-24-010354.Report this figure15.5Diluted shares (weighted), Q3 FY2023, three months to 2023-04-3015,518,072 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-06-14, accession 0001493152-24-023867.Report this figure16.7Diluted shares (weighted), Q1 FY2024, three months to 2023-10-3116,674,891 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-12-16, accession 0001493152-24-050214.Report this figure1.1Diluted shares (weighted), Q2 FY2024, three months to 2024-01-311,065,448 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-03-12, accession 0001493152-25-010052.Report this figure1.1Diluted shares (weighted), Q3 FY2024, three months to 2024-04-301,065,448 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-06-16, accession 0001641172-25-015265.Report this figure0.2Diluted shares (weighted), Q1 FY2025, three months to 2024-10-31177,606 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure0.3Diluted shares (weighted), Q2 FY2025, three months to 2025-01-31269,957 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure0.4Diluted shares (weighted), Q3 FY2025, three months to 2025-04-30373,067 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure1.9Diluted shares (weighted), Q1 FY2026, three months to 2025-10-311,883,906 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-12-11, accession 0001493152-25-027240.Report this figure2.8Diluted shares (weighted), Q2 FY2026, three months to 2026-01-312,802,337 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-03-10, accession 0001493152-26-009557.Report this figure7.3Diluted shares (weighted), Q3 FY2026, three months to 2026-04-307,250,487 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure

Shares outstanding: 8.70mShares outstanding, period not labelled, at 2026-06-098,699,787 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-06-09, accession 0001493152-26-027928.Report this figure at Jun 9, 2026, from the cover of the 10-Q filed Jun 9, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.